Mary Law
RES AST PROF
MD-PHARMACOLOGY - THERAPEUTICS
GRANTS
- GRANTBiomarker-directed repurposing of Omveloxolone for treatment of colon and pancreatic cancersOcala Royal Dames for Cancer Research24 Jun 2026 - 30 Jun 2028
- GRANTIsoform-Selective Disulfide Isomerase Inhibitors for Overcoming Drug ResistanceFlorida Breast Cancer Foundation8 Jul 2025 - 30 Jun 2026
- GRANTHER1-3 and Death Receptor protein folding as therapeutic vulnerabilitiesNational Institute of Health Nci7 Jul 2023 - 30 Jun 2026
- GRANTReducing racial disparity in breast cancer survival with a novel synthetic-lethal strategyFlorida Department of Health Biomed Research Pgm/J&E King26 Jun 2023 - 31 May 2026
- GRANTNovel Breast Cancer Therapeutics Targeting a Unique Subset of Disulfide IsomerasesFlorida Breast Cancer Foundation21 Jun 2022 - 30 Jun 2024
- GRANTRegulation of Death Receptor 5 folding and apoptotic signaling by AGR2National Institute of Health Nci16 Jul 2020 - 30 Jun 2023
- GRANTDual mechanisms of DDA antitumor activity: Induction of tumor cell apoptosis and vascular disruptionFlorida Breast Cancer Foundation10 Jul 2019 - 31 Dec 2020
- GRANTA new approach for eradicating metastatic, drug-resistant breast cancersOcala Royal Dames for Cancer Research20 Jun 2018 - 31 Dec 2020
- GRANTSynthetic lethal strategy for killing EGFR+/HER2+ cancersFlorida Breast Cancer Foundation16 Jan 2018 - 31 May 2019
- GRANTSmall-Molecule Inhibitors of NF-KappaB as a Novel Treatment Modality for Breast CancerCongressionally Directed Medical Research Programs24 Jul 2006 - 23 Aug 2008People funded by this grant:
- LAW M
- GRANTNational Institute of Diabetes and Digestive and Kidney Diseases15 Aug 2000 - 31 Jul 2003People funded by this grant:
- LAW ME
